Conference Date: 10-12 Dec 2012
Conference Ref: A12-1012
Fee: £1675 + VAT
Venue: The Cavendish Hotel, London
KEY TOPICS TO BE ADDRESSED AT THIS CONFERENCE:-
- Principles of Pharmacovigilance and Data Resources
- Risk Management and the development of the Pharmacovigilance Plan
- Causality Assessment: Clinical Diagnosis of Adverse Events
- Pharmacoepidemiological Studies
- PSURs and the link with DSURs and the EU risk management plan
- Proactive Pharmacovigilance Pre- and Post Marketing
- Pharmacovigilance Regulations (clinical trials & post-marketing)
- Risk/Benefit Analysis
- Dug Surveillance in countires outside Europe
- Post-marketing Surveillance: Observational Cohort Studies
- Global pharmacovigilance regulations and systems and their link with EU pharmacovigilance
- Practical Pharmacovigilance Workshop
CHAIRMEN:
Dr. Barry Arnold, Qualified Person for Pharmacovigilance, AstraZeneca R&D, UK
Dr. Glyn Belcher, Consultant, PV Consultanty Ltd. .
Professor Saad Shakir, Director Drug Safety Research Unit, UK
SPEAKERS
Dr. Carol Markwell, Drug Safety Solutions Ltd, UK
Dr John Parkinson, Director, Clinical Practice Research Datalink - MHRA, UK
Dr John Talbot, Senior Lecturer at University of Hertfordshire
Dr Lynda Wilton, Research Fellow, Centre Paediatric Pharmacy Research, School of Pharmacy, University of London.
Speaker from MHRA to be confirmed
For SPONSORSHIP and EXHIBITION opportunities at Management Forum events click here
To find out about EVENT MANAGEMENT click here
Speaking opportunities are available on selected Management Forum events, please click here for further information